Cargando…

Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS

Detalles Bibliográficos
Autores principales:	Scheibe, Franziska, Metz, Imke, Radbruch, Helena, Siebert, Eberhard, Wolf, Stefan, Köhnlein, Martin, Harms, Lutz, Meisel, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047475/ https://www.ncbi.nlm.nih.gov/pubmed/30027105 http://dx.doi.org/10.1212/NXI.0000000000000479

Ejemplares similares

A fatal case of daclizumab-induced liver failure in a patient with MS
por: Stettner, Mark, et al.
Publicado: (2019)

B-cell depletion is ineffective in a patient with granulomatous optic neuropathy
por: Wagner, Franziska, et al.
Publicado: (2018)

ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports
por: Körtvélyessy, Peter, et al.
Publicado: (2017)

GFAPα IgG-associated encephalitis upon daclizumab treatment of MS
por: Luessi, Felix, et al.
Publicado: (2018)

Management of MS Patients Treated With Daclizumab – a Case Series of 267 Patients
por: Rommer, Paulus S., et al.
Publicado: (2020)

Acute porphyrias – A neurological perspective
por: Gerischer, Lea M., et al.
Publicado: (2021)

Graves’ disease: an uncommon cause of late sequelae following DRESS (drug reaction with eosinophilia and systemic symptoms)
por: Tempark, Therdpong, et al.
Publicado: (2022)

Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination
por: Lin, Yen Chih, et al.
Publicado: (2016)

Pharmacodynamic effects of daclizumab in the intrathecal compartment
por: Komori, Mika, et al.
Publicado: (2017)

CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS
por: Elkins, J., et al.
Publicado: (2015)

Presence of SARS-CoV-2 Transcripts in the Choroid Plexus of MS and Non-MS Patients With COVID-19
por: Fuchs, Vidmante, et al.
Publicado: (2021)

Progressive multifocal leukoencephalopathy during fumarate monotherapy of psoriasis
por: Hoepner, Robert, et al.
Publicado: (2015)

A Case of Drug Reaction with Eosinophilia and Systemic Symptoms
por: Kellett, Sally, et al.
Publicado: (2012)

Drug reaction with eosinophilia and systemic symptoms (DRESS) in children
por: Francesca, Mori, et al.
Publicado: (2019)

Apremilast-associated drug reaction with eosinophilia and systemic symptoms
por: Chapman, Stephanie, et al.
Publicado: (2020)

Ganciclovir‐induced drug reaction with eosinophilia and systemic symptoms
por: Kitayama, Shohei, et al.
Publicado: (2023)

Spotlight on daclizumab: its potential in the treatment of multiple sclerosis
por: Milo, Ron, et al.
Publicado: (2016)

Glial Cells Express Nuclear Nrf2 After Fumarate Treatment for Multiple Sclerosis and Psoriasis
por: Metz, Imke, et al.
Publicado: (2015)

A case of CLIPPERS syndrome responsive to tocilizumab
por: Rempe, Torge, et al.
Publicado: (2019)

Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin
por: Singh, Jitendra, et al.
Publicado: (2016)

Drug reaction with eosinophilia and systemic symptoms without skin rash
por: Sasidharanpillai, Sarita, et al.
Publicado: (2015)

Levetiracetam Induced Drug Reaction with Eosinophilia and Systemic Symptom Syndrome
por: Dar, Waseem Raja, et al.
Publicado: (2016)

Griseofulvin associated with drug reaction with eosinophilia and systemic symptoms (DRESS)
por: Maiolo, Corinne, et al.
Publicado: (2016)

New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology
por: Musette, Philippe, et al.
Publicado: (2017)

Lithium-induced Drug Reaction with Eosinophilia and Systemic Symptom Syndrome
por: Bains, Anupama
Publicado: (2017)

Oxacillin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
por: Sharpe, Alexis, et al.
Publicado: (2019)

Valproate-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
por: Dwivedi, Arun Kumar, et al.
Publicado: (2018)

Drug Reaction with Eosinophilia and Systemic Symptom Syndrome Induced by Lamotrigine
por: Han, Song Hee, et al.
Publicado: (2017)

Liver involvement in the drug reaction, eosinophilia, and systemic symptoms syndrome
por: Martinez-Cabriales, Sylvia A, et al.
Publicado: (2019)

Chlorpromazine-induced Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome
por: Gowda, Shayanth Manche, et al.
Publicado: (2020)

Rosuvastatin Use Implicated in the Drug Reaction with Eosinophilia and Systemic Symptoms
por: Mustafa, Syed Farrukh, et al.
Publicado: (2020)

Alectinib-associated drug reaction with eosinophilia and systemic symptoms syndrome
por: Farooq, Sahira, et al.
Publicado: (2020)

Carbamazepine-associated Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome
por: Sharma, Ankush, et al.
Publicado: (2021)

Modafinil-induced drug reaction with eosinophilia and systemic symptoms syndrome
por: Kasitinon, Stacy Y., et al.
Publicado: (2022)

Drug Reaction With Eosinophilia and Systemic Symptoms: A Diagnostic Dilemma
por: Vecin, Nicole M, et al.
Publicado: (2023)

Drug-Induced Reaction With Eosinophilia and Systemic Symptoms: A Review
por: Alotaibi, Moteb
Publicado: (2023)

Editorial: Updates in drug reaction with eosinophilia and systemic symptoms (DRESS)
por: Janela, Baptiste, et al.
Publicado: (2023)

Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis
por: Lin, Yen Chih, et al.
Publicado: (2015)

Endocarditis following ocrelizumab in relapsing-remitting MS
por: Faissner, Simon, et al.
Publicado: (2020)

Eosinophilia and abdominal pain after severe pneumonia due to COVID 19()
por: Pintos-Pascual, Ilduara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q3hre9tn2mhhsiustjpbkopbk0